CBT
CRL icon

Central Bank & Trust’s Charles River Laboratories CRL Stock Holding History

Central Bank & Trust’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-6
Closed -$1.21K – 345
2023
Q1 		$1.21K Buy
+6
New +$1.36K ﹤0.01% 374
2022
Q2 		– Sell
-17,613
Closed -$5M – 320
2022
Q1 		$5M Buy
17,613
+12,484
+243% +$3.85M 0.8% 42
2021
Q4 		$1.93M Buy
+5,129
New +$1.99M 0.3% 72

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

Central Bank & Trust's CRL Position: Q2 2023 in Review

Central Bank & Trust sold out of Charles River Laboratories (CRL) in Q2 2023, closing a stake of 6 shares — an estimated $1.21K sold.

Central Bank & Trust first reported a position in CRL in Q4 2021 and held it in 3 quarters. The position peaked at $5M in Q1 2022. 612 funds tracked by Wall St. Rank hold CRL as of Q2 2023.

  • Central Bank & Trust reported no remaining Charles River Laboratories position as of Q2 2023 after selling out during the quarter.
  • Central Bank & Trust sold 6 Charles River Laboratories shares in Q2 2023, an estimated $1.21K.
  • Central Bank & Trust first reported a position in Charles River Laboratories in Q4 2021 and held it in 3 quarters.
  • Central Bank & Trust's Charles River Laboratories position peaked at $5M in Q1 2022.
  • 612 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2023.

Based on Central Bank & Trust's 13F filing for Q2 2023, filed 13 Jul 2023.